·Î°í
HOME CONTACT US
ȸ»ç¼Ò°³ °ÇÃà±â°è¼³ºñ°ø»ç ½ÅÀç»ý¿¡³ÊÁö(Áö¿­ ³Ã/³­¹æ) ä¿ëÁ¤º¸ °í°´¼¾ÅÍ ¹®ÀÇÇϱâ ÀÚ·á½Ç °øÁö»çÇ×
¹®ÀÇÇϱâ
ÀÚ·á½Ç
°øÁö»çÇ×
1:1 »ó´ã¸®½ºÆ®



  HOME > °í°´¼¾ÅÍ > ¹®ÀÇÇϱâ
Á¦¸ñ   UeVzzKAjdtqVboQfH
ÀÛ¼ºÀÚ   Rodger
ºñ¹Ð¹øÈ£   Á¶È¸¼ö   338
µî·ÏÀÏ   2019/09/28 (20:33)
³» ¿ë I work for a publishers http://xvideoxxx.in.net/ www.xvideo.com The plan, therefore, is to set up a framework that will enable researchers "to access a defined collection of AstraZeneca candidate drugs and their related data to enable such additional pre-clinical and clinical studies". The idea is to match AstraZeneca's "proven track record in global research and drug discovery" with NRPB’s and "academic thought-leaders’ insights", which may "accelerate the investigation of innovative hypotheses and technologies".
¸®½ºÆ®·Î ´ä±Û´Þ±â ¼öÁ¤Çϱâ Áö¿ì±â
[°ü·ÃµÈ ±Û º¸±â]
45106 UeVzzKAjdtqVboQfH Rodge.. 2019.09.28 338

ȸ»ç¼Ò°³
°ÇÃ༳ºñ°ø»ç
½ÅÀç»ý¿¡³ÊÁö
¿À½Ã´Â±æ
(ÁÖ)º¸¶÷¿£Áö´Ï¾î¸µ
ȸ»ç¼Ò°³ ¿À½Ã´Â±æ e-mail
1998 BORAM-ENG company. All rights reserved
[143-220] ¼­¿ïƯº°½Ã ±¤Áø±¸ Á߰ 341-18       Tel : 02)3437-0901